[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Micobiome Market Survey and Trend Research 2018

December 2017 | 92 pages | ID: G8BE840C6F5EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Vedanta, Seres Therapeutics, Second Genome, Rebiotix, Enterome BioScience, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC. etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Human Micobiome Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HUMAN MICOBIOME MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Vedanta (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Seres Therapeutics (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Second Genome (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Rebiotix (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Enterome BioScience (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Enterome BioScience (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 AvidBiotics (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 4D Pharma Research Ltd (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Enterologics (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Metabogen (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Metabiomics (Company Overview, Sales Data etc.)
4.12 Ritter Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Osel (Company Overview, Sales Data etc.)
4.14 Symberix (Company Overview, Sales Data etc.)
4.15 Miomics (Company Overview, Sales Data etc.)
4.16 Symbiotix Biotherapies (Company Overview, Sales Data etc.)
4.17 MicroBiome Therapeutics LLC. (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Human Micobiome Market 2012-2017, by Type, in USD Million
Table Global Human Micobiome Market 2012-2017, by Type, in Volume
Table Global Human Micobiome Market Forecast 2018-2023, by Type, in USD Million
Table Global Human Micobiome Market Forecast 2018-2023, by Type, in Volume
Table Vedanta Overview List
Table Human Micobiome Business Operation of Vedanta (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Seres Therapeutics Overview List
Table Human Micobiome Business Operation of Seres Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Second Genome Overview List
Table Human Micobiome Business Operation of Second Genome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Rebiotix Overview List
Table Human Micobiome Business Operation of Rebiotix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enterome BioScience Overview List
Table Human Micobiome Business Operation of Enterome BioScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enterome BioScience Overview List
Table Human Micobiome Business Operation of Enterome BioScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AvidBiotics Overview List
Table Human Micobiome Business Operation of AvidBiotics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 4D Pharma Research Ltd Overview List
Table Human Micobiome Business Operation of 4D Pharma Research Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enterologics Overview List
Table Human Micobiome Business Operation of Enterologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Metabogen Overview List
Table Human Micobiome Business Operation of Metabogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Metabiomics Overview List
Table Human Micobiome Business Operation of Metabiomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ritter Pharmaceuticals Overview List
Table Human Micobiome Business Operation of Ritter Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Osel Overview List
Table Human Micobiome Business Operation of Osel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symberix Overview List
Table Human Micobiome Business Operation of Symberix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Miomics Overview List
Table Human Micobiome Business Operation of Miomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symbiotix Biotherapies Overview List
Table Human Micobiome Business Operation of Symbiotix Biotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MicroBiome Therapeutics LLC. Overview List
Table Human Micobiome Business Operation of MicroBiome Therapeutics LLC. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Human Micobiome Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Human Micobiome Sales Revenue Share, by Companies, in USD Million
Table Global Human Micobiome Sales Volume 2012-2017, by Companies, in Volume
Table Global Human Micobiome Sales Revenue Share, by Companies in 2017, in Volume
Table Human Micobiome Demand 2012-2017, by Application, in USD Million
Table Human Micobiome Demand 2012-2017, by Application, in Volume
Table Human Micobiome Demand Forecast 2018-2023, by Application, in USD Million
Table Human Micobiome Demand Forecast 2018-2023, by Application, in Volume
Table Global Human Micobiome Market 2012-2017, by Region, in USD Million
Table Global Human Micobiome Market 2012-2017, by Region, in Volume
Table Human Micobiome Market Forecast 2018-2023, by Region, in USD Million
Table Human Micobiome Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Human Micobiome Industry Chain Structure
Figure Global Human Micobiome Market Growth 2012-2017, by Type, in USD Million
Figure Global Human Micobiome Market Growth 2012-2017, by Type, in Volume
Figure Global Human Micobiome Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Human Micobiome Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications